HBEGF and necrotizing enterocolitis: In addition, supplementation of formula with HB-EGF in a rat NEC model induced a dose dependent reduction of NEC incidence, with a therapeutic effect of moderate HB-EGF dosages that was not observed with either a low or a high HB-EGF dose [37].